Acurx Pharmaceuticals, Inc. (ACXP)

USD 0.31

(-3.13%)

Operating Income Summary of Acurx Pharmaceuticals, Inc.

  • Acurx Pharmaceuticals, Inc.'s latest annual operating income in 2023 was -14.57 Million USD , down -20.54% from previous year.
  • Acurx Pharmaceuticals, Inc.'s latest quarterly operating income in 2024 Q1 was -4.37 Million USD , up 14.4% from previous quarter.
  • Acurx Pharmaceuticals, Inc. reported an annual operating income of -12.09 Million USD in 2022, up 6.11% from previous year.
  • Acurx Pharmaceuticals, Inc. reported an annual operating income of -12.88 Million USD in 2021, down -180.01% from previous year.
  • Acurx Pharmaceuticals, Inc. reported a quarterly operating income of -4.12 Million USD for 2024 Q2, up 5.85% from previous quarter.
  • Acurx Pharmaceuticals, Inc. reported a quarterly operating income of -3.11 Million USD for 2023 Q3, up 99.91% from previous quarter.

Annual Operating Income Chart of Acurx Pharmaceuticals, Inc. (2023 - 2019)

Historical Annual Operating Income of Acurx Pharmaceuticals, Inc. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 -14.57 Million USD -20.54%
2022 -12.09 Million USD 6.11%
2021 -12.88 Million USD -180.01%
2020 -4.6 Million USD 22.44%
2019 -5.93 Million USD 0.0%

Peer Operating Income Comparison of Acurx Pharmaceuticals, Inc.

Name Operating Income Operating Income Difference
AbCellera Biologics Inc. -237.2 Million USD 93.854%
Alkermes plc 414.12 Million USD 103.52%
Agenus Inc. -159.54 Million USD 90.863%
Aptorum Group Limited -10.52 Million USD -38.528%
Ardelyx, Inc. -63.27 Million USD 76.962%
Dyadic International, Inc. -8.22 Million USD -77.135%
Eton Pharmaceuticals, Inc. -1.19 Million USD -1122.967%
Lantern Pharma Inc. -17.87 Million USD 18.458%
Inhibikase Therapeutics, Inc. -20.08 Million USD 27.437%
Novavax, Inc. -566.51 Million USD 97.427%
Janux Therapeutics, Inc. -72.97 Million USD 80.025%
Pyxis Oncology, Inc. -82.19 Million USD 82.265%
TransCode Therapeutics, Inc. -19.41 Million USD 24.929%
Ocuphire Pharma, Inc. -10.56 Million USD -38.008%
Outlook Therapeutics, Inc. -53.12 Million USD 72.56%
Madrigal Pharmaceuticals, Inc. -380.49 Million USD 96.169%
Reviva Pharmaceuticals Holdings, Inc. -24.3 Million USD 40.025%
SELLAS Life Sciences Group, Inc. -37.86 Million USD 61.505%
Syros Pharmaceuticals, Inc. -128.98 Million USD 88.698%
Barinthus Biotherapeutics plc -83.91 Million USD 82.628%
Windtree Therapeutics, Inc. -17.53 Million USD 16.884%
Xeris Biopharma Holdings, Inc. -44.01 Million USD 66.876%
Clearside Biomedical, Inc. -24.84 Million USD 41.323%
C4 Therapeutics, Inc. -139.03 Million USD 89.515%
Alnylam Pharmaceuticals, Inc. -282.17 Million USD 94.834%
AlloVir, Inc. -181.33 Million USD 91.961%
Arrowhead Pharmaceuticals, Inc. -205 Million USD 92.889%
VYNE Therapeutics Inc. -29.25 Million USD 50.175%
Bicycle Therapeutics plc -189.94 Million USD 92.325%
BioXcel Therapeutics, Inc. -171.78 Million USD 91.514%
ChromaDex Corporation -5.59 Million USD -160.364%
Chimerix, Inc. -93.06 Million USD 84.336%
Corbus Pharmaceuticals Holdings, Inc. -45.07 Million USD 67.661%
Caribou Biosciences, Inc. -116.05 Million USD 87.439%
CRISPR Therapeutics AG -222.53 Million USD 93.449%
Precision BioSciences, Inc. -43.73 Million USD 66.669%
Fate Therapeutics, Inc. -190.51 Million USD 92.348%
Fortress Biotech, Inc. -142.34 Million USD 89.759%
Fortress Biotech, Inc. -142.34 Million USD 89.759%
HOOKIPA Pharma Inc. -97.69 Million USD 85.078%
ImmuCell Corporation -5.74 Million USD -153.611%
IDEAYA Biosciences, Inc. -134.42 Million USD 89.156%
Immix Biopharma, Inc. -16.14 Million USD 9.685%
Incyte Corporation 620.52 Million USD 102.349%
Innoviva, Inc. 176.7 Million USD 108.25%
IO Biotech, Inc. -91.44 Million USD 84.058%
Jaguar Health, Inc. -34.29 Million USD 57.488%
Keros Therapeutics, Inc. -169.94 Million USD 91.422%
Ligand Pharmaceuticals Incorporated 11.94 Million USD 222.071%
ContextLogic Inc. -328 Million USD 95.556%
MiMedx Group, Inc. 37.11 Million USD 139.276%
MEI Pharma, Inc. 14.54 Million USD 200.246%
NextCure, Inc. -67.63 Million USD 78.447%
Onconetix, Inc. -36.03 Million USD 59.545%
Oncternal Therapeutics, Inc. -41.71 Million USD 65.053%
Opthea Limited -191.84 Million USD 92.401%
Psyence Biomedical Ltd. -2.75 Million USD -429.749%
Vaxcyte, Inc. -468.04 Million USD 96.885%
PDS Biotechnology Corporation -43.04 Million USD 66.134%
Precigen, Inc. -88.92 Million USD 83.606%
Pharming Group N.V. -4.87 Million USD -198.753%
Phathom Pharmaceuticals, Inc. -167.31 Million USD 91.287%
Pieris Pharmaceuticals, Inc. -29.75 Million USD 51.009%
PureTech Health plc -146.19 Million USD 90.029%
Rigel Pharmaceuticals, Inc. -20.49 Million USD 28.858%
Avidity Biosciences, Inc. -235.59 Million USD 93.812%
Reviva Pharmaceuticals Holdings, Inc. -24.3 Million USD 40.025%
Sangamo Therapeutics, Inc. -274 Million USD 94.68%
Sol-Gel Technologies Ltd. -29.3 Million USD 50.255%
Acelyrin, Inc. -422.06 Million USD 96.546%
Salarius Pharmaceuticals, Inc. -12.89 Thousand USD -112950.297%
Summit Therapeutics Inc. -89.73 Million USD 83.755%
Sensei Biotherapeutics, Inc. -37.06 Million USD 60.669%
Senti Biosciences, Inc. -92.72 Million USD 84.279%
Stoke Therapeutics, Inc. -114.77 Million USD 87.299%
Elevation Oncology, Inc. -45.44 Million USD 67.922%
Alaunos Therapeutics, Inc. -34.26 Million USD 57.458%
Telomir Pharmaceuticals, Inc. Common Stock -3.94 Million USD -269.802%
Entrada Therapeutics, Inc. -3.16 Million USD -361.03%
VistaGen Therapeutics, Inc. -33.02 Million USD 55.853%
Kintara Therapeutics, Inc. -8.5 Million USD -71.483%
Wave Life Sciences Ltd. -67.99 Million USD 78.561%
Seer, Inc. -103.46 Million USD 85.91%
Verrica Pharmaceuticals Inc. -65.75 Million USD 77.832%
Aadi Bioscience, Inc. -71.93 Million USD 79.734%
ESSA Pharma Inc. -32.13 Million USD 54.635%
GlycoMimetics, Inc. -39.27 Million USD 62.883%
GT Biopharma, Inc. -13.57 Million USD -7.379%
Inhibrx Biosciences, Inc. -219.22 Million USD 93.35%
Akebia Therapeutics, Inc. -46.25 Million USD 68.485%
Catalyst Pharmaceuticals, Inc. 86.81 Million USD 116.792%
Longboard Pharmaceuticals, Inc. -56.75 Million USD 74.316%
Orchestra BioMed Holdings, Inc. -51.5 Million USD 71.697%
Alzamend Neuro, Inc. -9.93 Million USD -46.692%
Sorrento Therapeutics, Inc. -504.31 Million USD 97.109%
TRACON Pharmaceuticals, Inc. -6.89 Million USD -111.333%
Viracta Therapeutics, Inc. -50.69 Million USD 71.243%
Rocket Pharmaceuticals, Inc. -259.65 Million USD 94.386%
Aptose Biosciences Inc. -52.35 Million USD 72.156%
ZyVersa Therapeutics, Inc. -14.42 Million USD -1.089%
Soligenix, Inc. -7.69 Million USD -89.372%
Century Therapeutics, Inc. -146.54 Million USD 90.052%
Kura Oncology, Inc. -165.8 Million USD 91.208%
TScan Therapeutics, Inc. -93.45 Million USD 84.402%
Intensity Therapeutics, Inc. -8.31 Million USD -75.235%
Ocean Biomedical, Inc. -2.48 Million USD -487.425%
CytomX Therapeutics, Inc. -6.48 Million USD -124.827%
Autolus Therapeutics plc -195.02 Million USD 92.525%
Mineralys Therapeutics, Inc. -84.65 Million USD 82.78%
EyePoint Pharmaceuticals, Inc. -73.66 Million USD 80.21%
Eterna Therapeutics Inc. -21.13 Million USD 31.025%
Adaptive Biotechnologies Corporation -227.03 Million USD 93.579%
GRI Bio, Inc. -11.38 Million USD -28.021%
Xenetic Biosciences, Inc. -4.51 Million USD -222.823%
Tenaya Therapeutics, Inc. -131.19 Million USD 88.888%
IGM Biosciences, Inc. -263.46 Million USD 94.467%
INmune Bio, Inc. -29.74 Million USD 50.984%
Heron Therapeutics, Inc. -110.61 Million USD 86.821%
SAB Biotherapeutics, Inc. -38.07 Million USD 61.713%
Pasithea Therapeutics Corp. -15.97 Million USD 8.771%
Entero Therapeutics, Inc. -15.77 Million USD 7.565%
Milestone Pharmaceuticals Inc. -61.09 Million USD 76.14%
X4 Pharmaceuticals, Inc. -107.52 Million USD 86.442%
Atara Biotherapeutics, Inc. -276 Million USD 94.718%
Coherus BioSciences, Inc. -203.19 Million USD 92.826%
Verastem, Inc. -92.08 Million USD 84.169%
Abeona Therapeutics Inc. -47.13 Million USD 69.072%
Pliant Therapeutics, Inc. -184.14 Million USD 92.084%
Tonix Pharmaceuticals Holding Corp. -118.38 Million USD 87.686%
Histogen Inc. -10.64 Million USD -36.97%
Aprea Therapeutics, Inc. -15.47 Million USD 5.779%
Surrozen, Inc. -45.78 Million USD 68.157%
Organovo Holdings, Inc. -15.08 Million USD 3.369%
Lixte Biotechnology Holdings, Inc. -5.09 Million USD -186.387%
Ovid Therapeutics Inc. -59.28 Million USD 75.409%
Panbela Therapeutics, Inc. -51.29 Million USD 71.58%
CASI Pharmaceuticals, Inc. -25.28 Million USD 42.335%
Cadrenal Therapeutics, Inc. Common Stock -7.63 Million USD -90.987%
Centessa Pharmaceuticals plc -171.28 Million USD 91.489%
Hepion Pharmaceuticals, Inc. -48.44 Million USD 69.91%
Arcturus Therapeutics Holdings Inc. -78.2 Million USD 81.36%
BioRestorative Therapies, Inc. -15.22 Million USD 4.225%
Apollomics, Inc. -54.83 Million USD 73.415%
Amarin Corporation plc -67.58 Million USD 78.431%
Mesoblast Limited -58.79 Million USD 75.205%
Turnstone Biologics Corp. -59.03 Million USD 75.305%
Kymera Therapeutics, Inc. -165.53 Million USD 91.193%
Synaptogenix, Inc. -8.31 Million USD -75.343%
Tiziana Life Sciences Ltd -14.58 Million USD 0.056%
Aurinia Pharmaceuticals Inc. -91.69 Million USD 84.101%
BriaCell Therapeutics Corp. -4.79 Million USD -204.244%
Monopar Therapeutics Inc. -8.83 Million USD -65.071%
Exelixis, Inc. 170.88 Million USD 108.531%
Better Therapeutics, Inc. -38.26 Million USD 61.9%
Nurix Therapeutics, Inc. -155.06 Million USD 90.599%
Apellis Pharmaceuticals, Inc. -517.12 Million USD 97.181%
NLS Pharmaceutics AG -11.8 Million USD -23.467%
Dermata Therapeutics, Inc. -8.04 Million USD -81.273%
Aridis Pharmaceuticals, Inc. -29.99 Million USD 51.396%
Gritstone bio, Inc. -154.63 Million USD 90.573%
Jasper Therapeutics, Inc. -68.86 Million USD 78.83%
TNF Pharmaceuticals, Inc. -17.12 Million USD 14.865%
Avid Bioservices, Inc. -18.67 Million USD 21.952%
Insmed Incorporated -709.62 Million USD 97.946%
Virpax Pharmaceuticals, Inc. -15.68 Million USD 7.088%
MediWound Ltd. -15.29 Million USD 4.658%
OmniAb, Inc. -69.41 Million USD 79.0%
Alector, Inc. -151.74 Million USD 90.393%
Seres Therapeutics, Inc. -107.98 Million USD 86.5%
Checkpoint Therapeutics, Inc. -52.14 Million USD 72.045%
Zai Lab Limited -366.57 Million USD 96.023%
Revance Therapeutics, Inc. -316.77 Million USD 95.398%
Aura Biosciences, Inc. -84.99 Million USD 82.848%
Lyell Immunopharma, Inc. -245.49 Million USD 94.062%
Immunic, Inc. -99.22 Million USD 85.308%
Tarsus Pharmaceuticals, Inc. -143.15 Million USD 89.817%
Veracyte, Inc. -85.79 Million USD 83.009%
InMed Pharmaceuticals Inc. - USD Infinity%
FibroGen, Inc. -281.81 Million USD 94.827%
SeaStar Medical Holding Corporation -14.21 Million USD -2.588%
Adial Pharmaceuticals, Inc. -6.88 Million USD -111.642%
Sonnet BioTherapeutics Holdings, Inc. -18.79 Million USD 22.428%
Jazz Pharmaceuticals plc 578.58 Million USD 102.52%
Cyclacel Pharmaceuticals, Inc. -25.45 Million USD 42.727%
Amylyx Pharmaceuticals, Inc. 38.8 Million USD 137.57%
TG Therapeutics, Inc. 20.63 Million USD 170.653%
Galecto, Inc. -39.9 Million USD 63.469%
Calithera Biosciences, Inc. -42.07 Million USD 65.352%
Fortrea Holdings Inc. 63.1 Million USD 123.103%
KalVista Pharmaceuticals, Inc. -140.44 Million USD 89.62%
Aptevo Therapeutics Inc. -28.87 Million USD 49.519%
XBiotech Inc. -37.51 Million USD 61.136%
Jasper Therapeutics, Inc. -68.86 Million USD 78.83%
Lyra Therapeutics, Inc. -67.12 Million USD 78.281%
Foghorn Therapeutics Inc. -107.9 Million USD 86.49%
Y-mAbs Therapeutics, Inc. -25.67 Million USD 43.215%
Theravance Biopharma, Inc. -53.29 Million USD 72.645%
Ultragenyx Pharmaceutical Inc. -569.2 Million USD 97.439%
Metagenomi, Inc. Common Stock -78.49 Million USD 81.428%
Vaxxinity, Inc. -58.28 Million USD 74.989%
BioCryst Pharmaceuticals, Inc. -103.7 Million USD 85.944%
Gain Therapeutics, Inc. -22.25 Million USD 34.491%
Cartesian Therapeutics, Inc. -86.41 Million USD 83.131%
NexImmune, Inc. -29.19 Million USD 50.063%
Creative Medical Technology Holdings, Inc. -5.62 Million USD -159.385%
Marker Therapeutics, Inc. -14.58 Million USD 0.025%
Regeneron Pharmaceuticals, Inc. 4.04 Billion USD 100.36%
Chemomab Therapeutics Ltd. -25.45 Million USD 42.74%
Scopus BioPharma Inc. -11.71 Million USD -24.438%
RAPT Therapeutics, Inc. -127.06 Million USD 88.527%
Ainos, Inc. -13.2 Million USD -10.384%
Pluri Inc. -22.15 Million USD 34.21%
Prothena Corporation plc -191.03 Million USD 92.369%
Adaptimmune Therapeutics plc -138.03 Million USD 89.439%
Celularity Inc. -192.28 Million USD 92.419%
Rallybio Corporation -78.93 Million USD 81.531%
Cue Biopharma, Inc. -52.14 Million USD 72.046%
MeiraGTx Holdings plc -137.06 Million USD 89.364%
Omeros Corporation -164.53 Million USD 91.14%
Humacyte, Inc. -100.04 Million USD 85.429%
Immunocore Holdings plc -59.64 Million USD 75.561%
Cocrystal Pharma, Inc. -18.55 Million USD 21.452%
Cidara Therapeutics, Inc. -24.48 Million USD 40.458%
Blueprint Medicines Corporation -486.27 Million USD 97.002%
CalciMedica, Inc. -21.87 Million USD 33.359%
Cabaletta Bio, Inc. -74.66 Million USD 80.474%
Marinus Pharmaceuticals, Inc. -131.48 Million USD 88.913%
Scholar Rock Holding Corporation -171.29 Million USD 91.49%
Sana Biotechnology, Inc. -326.9 Million USD 95.541%
Pulmatrix, Inc. -14.74 Million USD 1.101%
Elicio Therapeutics, Inc. -35.74 Million USD 59.217%
Vigil Neuroscience, Inc. -88.86 Million USD 83.596%
Intellia Therapeutics, Inc. -515.29 Million USD 97.171%
Adlai Nortye Ltd. American Depositary Shares -67.55 Million USD 78.42%
Cytokinetics, Incorporated -496.2 Million USD 97.062%
Eloxx Pharmaceuticals, Inc. -34.41 Million USD 57.646%
Nutriband Inc. -4.87 Million USD -199.22%
Protara Therapeutics, Inc. -43.61 Million USD 66.575%
Vor Biopharma Inc. -126.03 Million USD 88.434%
Roivant Sciences Ltd. 4.24 Billion USD 100.344%
Evogene Ltd. -26.39 Million USD 44.762%
ProKidney Corp. -151.52 Million USD 90.379%
Applied Therapeutics, Inc. -64.53 Million USD 77.411%
Hoth Therapeutics, Inc. -7.69 Million USD -89.513%
BridgeBio Pharma, Inc. -607.37 Million USD 97.6%
CorMedix Inc. -48.95 Million USD 70.224%
BioLineRx Ltd. -49.69 Million USD 70.665%
Tango Therapeutics, Inc. -114.17 Million USD 87.232%
Galectin Therapeutics Inc. -38.07 Million USD 61.71%
Atai Life Sciences N.V. -125.47 Million USD 88.382%
Renovaro Biosciences Inc. -81.63 Million USD 82.144%
Aerovate Therapeutics, Inc. -81.4 Million USD 82.093%
Zentalis Pharmaceuticals, Inc. -248.98 Million USD 94.145%
Sagimet Biosciences Inc. -30.74 Million USD 52.577%
MediciNova, Inc. -9.9 Million USD -47.246%
Praxis Precision Medicines, Inc. -126.37 Million USD 88.464%
Cardio Diagnostics Holdings, Inc. -7.24 Million USD -101.282%
GeoVax Labs, Inc. -26.74 Million USD 45.489%
Axsome Therapeutics, Inc. -231.82 Million USD 93.712%
Biomea Fusion, Inc. -126.13 Million USD 88.443%
PTC Therapeutics, Inc. -349.4 Million USD 95.828%
Mereo BioPharma Group plc -28.41 Million USD 48.699%
Cullinan Oncology, Inc. -191.08 Million USD 92.371%
Syndax Pharmaceuticals, Inc. -229.95 Million USD 93.661%
Absci Corporation -115.51 Million USD 87.38%
NRx Pharmaceuticals, Inc. -27.58 Million USD 47.157%
4D Molecular Therapeutics, Inc. -112.86 Million USD 87.084%
Dyne Therapeutics, Inc. -242.16 Million USD 93.98%
Kiniksa Pharmaceuticals, Ltd. -25.19 Million USD 42.143%
Ventyx Biosciences, Inc. -207.99 Million USD 92.991%
Allakos Inc. -196.05 Million USD 92.564%
Imunon, Inc. -21.03 Million USD 30.683%
Fulcrum Therapeutics, Inc. -110.66 Million USD 86.827%
Corcept Therapeutics Incorporated 107.28 Million USD 113.588%
BioAtla, Inc. -129.68 Million USD 88.759%
NLS Pharmaceutics AG -11.8 Million USD -23.467%
Bio-Path Holdings, Inc. -15.84 Million USD 7.986%
Allogene Therapeutics, Inc. -327.73 Million USD 95.552%
Larimar Therapeutics, Inc. -41.75 Million USD 65.09%
XOMA Corporation -41.84 Million USD 65.165%
Kezar Life Sciences, Inc. -105.23 Million USD 86.148%
Cara Therapeutics, Inc. -121.49 Million USD 88.001%
aTyr Pharma, Inc. -54.91 Million USD 73.456%
Aligos Therapeutics, Inc. -87.42 Million USD 83.326%
Akero Therapeutics, Inc. -172.87 Million USD 91.567%
Viridian Therapeutics, Inc. -254.45 Million USD 94.271%
Eliem Therapeutics, Inc. -21.46 Million USD 32.089%
EyeGate Pharmaceuticals, Inc. -8.21 Million USD -77.502%
Akari Therapeutics, Plc -16.8 Million USD 13.259%
Tevogen Bio Holdings Inc. -8843.03 USD -164750.374%
Halozyme Therapeutics, Inc. 337.57 Million USD 104.318%
Lexaria Bioscience Corp. -6.53 Million USD -123.106%
UroGen Pharma Ltd. -65.53 Million USD 77.756%
Sutro Biopharma, Inc. -89.27 Million USD 83.671%
ZIVO Bioscience, Inc. -7.26 Million USD -100.712%
Orgenesis Inc. -53.63 Million USD 72.821%
Entera Bio Ltd. -8.89 Million USD -63.961%
GH Research PLC -41.22 Million USD 64.636%
Lisata Therapeutics, Inc. -25.7 Million USD 43.295%
Reneo Pharmaceuticals, Inc. -83.05 Million USD 82.448%
Xencor, Inc. -138.63 Million USD 89.485%
60 Degrees Pharmaceuticals, Inc. -5.15 Million USD -182.812%
Replimune Group, Inc. -234.77 Million USD 93.791%
Coeptis Therapeutics Holdings, Inc. -21.49 Million USD 32.168%
Vanda Pharmaceuticals Inc. -13.95 Million USD -4.485%
Lexaria Bioscience Corp. -6.53 Million USD -123.106%
Portage Biotech Inc. -18.25 Million USD 20.135%
Cardio Diagnostics Holdings, Inc. -7.24 Million USD -101.282%
Olema Pharmaceuticals, Inc. -104.96 Million USD 86.111%
OncoCyte Corporation -25.13 Million USD 42.004%
Qualigen Therapeutics, Inc. -11.3 Million USD -28.951%
Processa Pharmaceuticals, Inc. -11.45 Million USD -27.238%
Purple Biotech Ltd. 22.27 Million USD 165.456%
CollPlant Biotechnologies Ltd. -7.51 Million USD -94.06%
scPharmaceuticals Inc. -55.39 Million USD 73.684%
ProMIS Neurosciences, Inc. -18.89 Million USD 22.86%
HilleVax, Inc. -133.34 Million USD 89.068%
NeuroSense Therapeutics Ltd. -12.04 Million USD -20.987%
Tharimmune, Inc. -9.45 Million USD -54.177%
Genprex, Inc. -31.07 Million USD 53.089%
Neumora Therapeutics, Inc. Common Stock -188.19 Million USD 92.254%
Atossa Therapeutics, Inc. -31.37 Million USD 53.54%
XTL Biopharmaceuticals Ltd. -765 Thousand USD -1805.591%
Virios Therapeutics, Inc. -5.44 Million USD -167.633%
OKYO Pharma Limited -15.74 Thousand USD -92458.844%
Savara Inc. -60 Million USD 75.707%
Curis, Inc. -48.33 Million USD 69.838%
Daré Bioscience, Inc. -30.83 Million USD 52.731%
Carmell Therapeutics Corporation -5.21 Million USD -179.413%
Titan Pharmaceuticals, Inc. -7.27 Million USD -100.327%
Achieve Life Sciences, Inc. -27.25 Million USD 46.504%
BeiGene, Ltd. -1.2 Billion USD 98.793%
Kiromic BioPharma, Inc. -19.93 Million USD 26.889%
Revolution Medicines, Inc. Warrant -487.18 Million USD 97.008%
Protagonist Therapeutics, Inc. -93.65 Million USD 84.434%
Erasca, Inc. -141.52 Million USD 89.7%
bluebird bio, Inc. -244.26 Million USD 94.032%
Protagenic Therapeutics, Inc. -4.52 Million USD -222.02%
BioMarin Pharmaceutical Inc. 194.44 Million USD 107.497%
DBV Technologies S.A. -76.43 Million USD 80.927%
Protagenic Therapeutics, Inc. -4.52 Million USD -222.02%
Moderna, Inc. -4.23 Billion USD 99.656%
Vincerx Pharma, Inc. -42.6 Million USD 65.787%
Fresh Tracks Therapeutics, Inc. -6.36 Million USD -129.21%
Molecular Templates, Inc. -10.46 Million USD -39.287%
Acrivon Therapeutics, Inc. Common Stock -67.23 Million USD 78.319%
Travere Therapeutics, Inc. -376.74 Million USD 96.131%
Monte Rosa Therapeutics, Inc. -143.31 Million USD 89.828%
Spruce Biosciences, Inc. -51.99 Million USD 71.962%
Celldex Therapeutics, Inc. -154.54 Million USD 90.567%
Cogent Biosciences, Inc. -208.13 Million USD 92.996%
MacroGenics, Inc. -168.24 Million USD 91.335%
RenovoRx, Inc. -11.39 Million USD -27.92%
Adicet Bio, Inc. -152.03 Million USD 90.412%
Prime Medicine, Inc. -191.29 Million USD 92.379%
Aditxt, Inc. -26.06 Million USD 44.066%
Adagene Inc. -23.71 Million USD 38.542%
Estrella Immunopharma, Inc. -7.31 Million USD -99.42%
Quantum-Si incorporated -111.17 Million USD 86.887%
Maravai LifeSciences Holdings, Inc. -31.64 Million USD 53.938%
Voyager Therapeutics, Inc. 122.01 Million USD 111.948%
SciSparc Ltd. -5.77 Million USD -152.516%
Vericel Corporation -6.46 Million USD -125.522%
Revelation Biosciences, Inc. -8.65 Million USD -68.399%
Minerva Neurosciences, Inc. -23.11 Million USD 36.946%
Generation Bio Co. -138.56 Million USD 89.479%
Astria Therapeutics, Inc. -83.03 Million USD 82.443%
Black Diamond Therapeutics, Inc. -86.46 Million USD 83.139%
Arcutis Biotherapeutics, Inc. -241.1 Million USD 93.954%
Invivyd, Inc. -207.78 Million USD 92.984%
Relay Therapeutics, Inc. -373 Million USD 96.092%
Quoin Pharmaceuticals, Ltd. -9.37 Million USD -55.438%
Spero Therapeutics, Inc. 21.48 Million USD 167.864%
Artelo Biosciences, Inc. -10.28 Million USD -41.711%
2seventy bio, Inc. -216.7 Million USD 93.273%
ADMA Biologics, Inc. 21.63 Million USD 167.39%
Clene Inc. -40.54 Million USD 64.041%
Capricor Therapeutics, Inc. -24.07 Million USD 39.456%
Boundless Bio, Inc. Common Stock -54.79 Million USD 73.396%
GeoVax Labs, Inc. -26.74 Million USD 45.489%
Recursion Pharmaceuticals, Inc. -350.06 Million USD 95.836%
Citius Pharmaceuticals, Inc. -36.73 Million USD 60.313%
Contineum Therapeutics, Inc. Class A Common Stock 16.07 Million USD 190.675%
Relmada Therapeutics, Inc. -103.7 Million USD 85.943%
Finch Therapeutics Group, Inc. -34 Million USD 57.127%
ALX Oncology Holdings Inc. -170.27 Million USD 91.439%
Vir Biotechnology, Inc. -684.3 Million USD 97.87%
Evaxion Biotech A/S -22.19 Million USD 34.326%
Ocular Therapeutix, Inc. -82.38 Million USD 82.305%
Verve Therapeutics, Inc. -223.12 Million USD 93.467%
Trevena, Inc. -35.28 Million USD 58.689%
Surrozen, Inc. -45.78 Million USD 68.157%
Tyra Biosciences, Inc. -79.94 Million USD 81.765%
Cingulate Inc. -22.75 Million USD 35.948%
Galmed Pharmaceuticals Ltd. 7.49 Million USD 294.578%
Unity Biotechnology, Inc. -44.66 Million USD 67.363%
Tenax Therapeutics, Inc. -8.23 Million USD -77.045%
Terns Pharmaceuticals, Inc. -102.55 Million USD 85.786%
ACADIA Pharmaceuticals Inc. -73.37 Million USD 80.134%
Connect Biopharma Holdings Limited -62.07 Million USD 76.516%
Clearmind Medicine Inc. -8.74 Million USD -66.768%
Kronos Bio, Inc. -121.83 Million USD 88.034%
Bolt Biotherapeutics, Inc. -76.19 Million USD 80.868%
CERo Therapeutics Holdings, Inc. -2.93 Million USD -397.028%
Viking Therapeutics, Inc. -100.82 Million USD 85.542%
Statera Biopharma, Inc. -98.34 Million USD 85.177%
ImmunityBio, Inc. -362.25 Million USD 95.976%
Korro Bio, Inc. -84.53 Million USD 82.755%
Kineta, Inc. -15.72 Million USD 7.284%
BioVie Inc. -32.17 Million USD 54.699%
Codexis, Inc. -68.06 Million USD 78.584%
Celularity Inc. -192.28 Million USD 92.419%
Crinetics Pharmaceuticals, Inc. -222.6 Million USD 93.451%
Celcuity Inc. -66.23 Million USD 77.989%
Virax Biolabs Group Limited -6.49 Million USD -124.395%
Cibus, Inc. -318.88 Million USD 95.428%
Eledon Pharmaceuticals, Inc. -43 Million USD 66.098%
eFFECTOR Therapeutics, Inc. -33.84 Million USD 56.927%
IN8bio, Inc. -30.33 Million USD 51.947%
Kodiak Sciences Inc. -277.32 Million USD 94.743%
Annexon, Inc. -143.72 Million USD 89.857%
Adverum Biotechnologies, Inc. -123.79 Million USD 88.224%
Assembly Biosciences, Inc. -64.64 Million USD 77.45%
Avalo Therapeutics, Inc. -23.44 Million USD 37.819%
Ionis Pharmaceuticals, Inc. -353.73 Million USD 95.879%
Eyenovia, Inc. -25.4 Million USD 42.622%
Puma Biotechnology, Inc. 32.64 Million USD 144.662%
Conduit Pharmaceuticals Inc. -5.56 Million USD -162.096%
Xilio Therapeutics, Inc. -79.13 Million USD 81.578%
Arcellx, Inc. -89.88 Million USD 83.781%
Cardiff Oncology, Inc. -45.41 Million USD 67.899%
Enanta Pharmaceuticals, Inc. -137.2 Million USD 89.375%
Regulus Therapeutics Inc. -31.1 Million USD 53.14%
Moolec Science SA -6.65 Million USD -119.089%
Acumen Pharmaceuticals, Inc. -61.13 Million USD 76.156%
Geron Corporation -193.94 Million USD 92.484%
LAVA Therapeutics N.V. -43.25 Million USD 66.297%
Royalty Pharma plc 1.49 Billion USD 100.977%
Atea Pharmaceuticals, Inc. -164.16 Million USD 91.12%
Greenwich LifeSciences, Inc. -9.32 Million USD -56.282%
TFF Pharmaceuticals, Inc. -21.89 Million USD 33.419%
Mersana Therapeutics, Inc. -170.95 Million USD 91.473%
Humacyte, Inc. -100.04 Million USD 85.429%
Structure Therapeutics Inc. -102.77 Million USD 85.816%
89bio, Inc. -151.2 Million USD 90.359%
PMV Pharmaceuticals, Inc. -80.13 Million USD 81.808%
Avenue Therapeutics, Inc. -14.54 Million USD -0.26%
Genelux Corporation -24.16 Million USD 39.674%
Trevi Therapeutics, Inc. -33.92 Million USD 57.027%
Lexicon Pharmaceuticals, Inc. -171.75 Million USD 91.512%
Notable Labs, Ltd. -14.65 Million USD 0.541%
Liquidia Corporation -73.38 Million USD 80.135%
Mustang Bio, Inc. -50.72 Million USD 71.262%
Immunovant, Inc. -282.7 Million USD 94.844%
Quantum-Si incorporated -111.17 Million USD 86.887%
Arbutus Biopharma Corporation -78.1 Million USD 81.335%
DiaMedica Therapeutics Inc. -21.26 Million USD 31.454%
Vera Therapeutics, Inc. -102.01 Million USD 85.71%
Acasti Pharma Inc. -11.31 Million USD -28.87%
MiNK Therapeutics, Inc. -22.92 Million USD 36.4%
Pasithea Therapeutics Corp. -15.97 Million USD 8.771%
Xenon Pharmaceuticals Inc. -214.05 Million USD 93.19%
Elevai Labs, Inc. Common Stock -3.66 Million USD -297.315%
NeuroBo Pharmaceuticals, Inc. -15.88 Million USD 8.235%
Tempest Therapeutics, Inc. -29.15 Million USD 50.003%
Soleno Therapeutics, Inc. -41.38 Million USD 64.774%
PepGen Inc. -84.76 Million USD 82.802%
Moleculin Biotech, Inc. -29.63 Million USD 50.802%
United Therapeutics Corporation 1.18 Billion USD 101.23%
Nuvectis Pharma, Inc. -22.89 Million USD 36.333%
Solid Biosciences Inc. -104.31 Million USD 86.025%
BriaCell Therapeutics Corp. -32.8 Million USD 55.567%
Immuneering Corporation -58.41 Million USD 75.044%
Lixte Biotechnology Holdings, Inc. -5.09 Million USD -186.387%
Silo Pharma, Inc. -3.85 Million USD -278.094%
Belite Bio, Inc -31.66 Million USD 53.967%
XOMA Corporation -41.84 Million USD 65.165%
ARS Pharmaceuticals, Inc. -67.52 Million USD 78.41%
Bionomics Limited -17.89 Billion USD 99.919%
Apogee Therapeutics, Inc. -93 Million USD 84.325%
Alpha Tau Medical Ltd. 35.68 Million USD 140.857%
uniQure N.V. -282.87 Million USD 94.846%
Cassava Sciences, Inc. -105.95 Million USD 86.242%
Estrella Immunopharma, Inc. -7.31 Million USD -99.42%
Poseida Therapeutics, Inc. -129.5 Million USD 88.743%
Forte Biosciences, Inc. -32.48 Million USD 55.126%
Anebulo Pharmaceuticals, Inc. -8.3 Million USD -75.451%
Enlivex Therapeutics Ltd. -29.39 Million USD 50.407%
Conduit Pharmaceuticals Inc. -5.56 Million USD -162.096%
SeaStar Medical Holding Corporation -14.21 Million USD -2.588%
FibroBiologics, Inc. Common Stock -8.88 Million USD -63.998%
Altimmune, Inc. -95.92 Million USD 84.804%
Amicus Therapeutics, Inc. -73.49 Million USD 80.165%
Alpha Tau Medical Ltd. 35.68 Million USD 140.857%
Compugen Ltd. -12.99 Million USD -12.206%
Peak Bio, Inc. -1356.23 USD -1074774.321%
Zevra Therapeutics, Inc. -49.6 Million USD 70.612%
Benitec Biopharma Inc. -22.49 Million USD 35.181%
Spyre Therapeutics, Inc. -242.3 Million USD 93.984%
NKGen Biotech, Inc. Common Stock -29.74 Million USD 50.993%
Zura Bio Limited -62.63 Million USD 76.727%
PolyPid Ltd. -22.86 Million USD 36.25%
Aileron Therapeutics, Inc. -16.27 Million USD 10.434%
NKGen Biotech, Inc. Warrants -29.74 Million USD 50.993%
Instil Bio, Inc. -159.16 Million USD 90.841%
argenx SE -425.04 Million USD 96.57%
Immunome, Inc. -109.53 Million USD 86.691%
Compass Therapeutics, Inc. -50.36 Million USD 71.055%
Verona Pharma plc -67.83 Million USD 78.509%
enGene Holdings Inc. Warrants -26.06 Million USD 44.061%
Shattuck Labs, Inc. -91.95 Million USD 84.147%
CervoMed Inc. -7.81 Million USD -86.586%
LENZ Therapeutics, Inc. -73.11 Million USD 80.061%
Plus Therapeutics, Inc. -13.32 Million USD -9.434%
Dianthus Therapeutics, Inc. -48.17 Million USD 69.739%
Moolec Science SA -6.65 Million USD -119.089%
Enveric Biosciences, Inc. -16.44 Million USD 11.373%
Inovio Pharmaceuticals, Inc. -135.22 Million USD 89.22%
AnaptysBio, Inc. -164.41 Million USD 91.133%
Design Therapeutics, Inc. -78.19 Million USD 81.356%
Leap Therapeutics, Inc. -87.04 Million USD 83.252%
NeurAxis, Inc. -6.66 Million USD -118.738%
Seelos Therapeutics, Inc. -40.49 Million USD 64.005%
Lumos Pharma, Inc. -36.61 Million USD 60.185%
Achilles Therapeutics plc -75.25 Million USD 80.629%
enGene Holdings Inc. Common Stock -26.06 Million USD 44.061%
180 Life Sciences Corp. -13.47 Million USD -8.164%
Opiant Pharmaceuticals, Inc. 5.15 Million USD 382.717%
CERo Therapeutics Holdings, Inc. -2.93 Million USD -397.028%
Nutriband Inc. -4.87 Million USD -199.22%
ORIC Pharmaceuticals, Inc. -110.78 Million USD 86.841%
CG Oncology, Inc. Common stock -55.44 Million USD 73.71%
Fractyl Health, Inc. Common Stock -50.83 Million USD 71.324%
Rani Therapeutics Holdings, Inc. -66.09 Million USD 77.946%
MoonLake Immunotherapeutics -54.12 Million USD 73.066%
Palisade Bio, Inc. -13.07 Million USD -11.536%
Tourmaline Bio, Inc. -45.4 Million USD 67.897%
Beam Therapeutics Inc. -176.48 Million USD 91.74%
Neurogene Inc. -55.58 Million USD 73.773%
Mirum Pharmaceuticals, Inc. -109.15 Million USD 86.645%
AEON Biopharma, Inc. -48.42 Million USD 69.899%
CARGO Therapeutics, Inc. Common Stock -96.71 Million USD 84.926%
Sesen Bio, Inc. -25.9 Million USD 43.735%
Enliven Therapeutics, Inc. -83.52 Million USD 82.548%
Kiora Pharmaceuticals, Inc. -12.58 Million USD -15.817%
Iovance Biotherapeutics, Inc. -460.55 Million USD 96.835%
Taysha Gene Therapies, Inc. -72.43 Million USD 79.876%
Athira Pharma, Inc. -125.46 Million USD 88.381%
Vaccinex, Inc. -22.88 Million USD 36.3%
HCW Biologics Inc. -25.71 Million USD 43.315%
XOMA Corporation -41.84 Million USD 65.165%
Nektar Therapeutics -137.42 Million USD 89.392%
Arvinas, Inc. -401.5 Million USD 96.369%
Tevogen Bio Holdings Inc. -8843.03 USD -164750.374%
Merus N.V. -156.54 Million USD 90.688%
Omega Therapeutics, Inc. -100.26 Million USD 85.46%
Quince Therapeutics, Inc. -34.62 Million USD 57.892%
Rezolute, Inc. -70.42 Million USD 79.3%
Clene Inc. -40.54 Million USD 64.041%
Indaptus Therapeutics, Inc. -16.37 Million USD 10.994%
BeyondSpring Inc. -23.11 Million USD 36.931%
Synlogic, Inc. -55.16 Million USD 73.572%
Allarity Therapeutics, Inc. -17.92 Million USD 18.692%
Phio Pharmaceuticals Corp. -10.82 Million USD -34.68%
Peak Bio, Inc. -1356.23 USD -1074774.321%
Werewolf Therapeutics, Inc. -40.5 Million USD 64.008%
Krystal Biotech, Inc. -109.72 Million USD 86.715%
Karyopharm Therapeutics Inc. -129.53 Million USD 88.747%
SpringWorks Therapeutics, Inc. -343.01 Million USD 95.75%
Lipella Pharmaceuticals Inc. -4.74 Million USD -207.162%
MannKind Corporation 8.67 Million USD 267.985%
Ikena Oncology, Inc. -75.41 Million USD 80.67%
Cyclerion Therapeutics, Inc. -9.64 Million USD -51.112%
Gyre Therapeutics, Inc. -67.23 Million USD 78.317%
Gossamer Bio, Inc. -183.75 Million USD 92.067%
CohBar, Inc. -12.38 Million USD -17.674%
Cognition Therapeutics, Inc. -50.72 Million USD 71.261%
NRx Pharmaceuticals, Inc. -27.58 Million USD 47.157%
Legend Biotech Corporation -439.48 Million USD 96.683%
Mural Oncology plc -194.63 Million USD 92.51%
Biora Therapeutics, Inc. -67.14 Million USD 78.288%
PaxMedica, Inc. Common Stock -16.14 Million USD 9.709%
Disc Medicine, Inc. -91.12 Million USD 84.002%
Champions Oncology, Inc. -7.35 Million USD -98.175%
REGENXBIO Inc. -268.12 Million USD 94.563%
Ensysce Biosciences, Inc. -10.71 Million USD -36.01%
Anavex Life Sciences Corp. -55.75 Million USD 73.854%
Cellectar Biosciences, Inc. -38.96 Million USD 62.583%
Edgewise Therapeutics, Inc. -114.35 Million USD 87.252%
Vaxart, Inc. -83.34 Million USD 82.51%
PharmaCyte Biotech, Inc. -8.52 Million USD -71.1%
Aldeyra Therapeutics, Inc. -42.79 Million USD 65.935%
Cellectis S.A. -106.62 Million USD 86.328%
Longeveron Inc. -21.02 Million USD 30.678%
Repare Therapeutics Inc. -116.22 Million USD 87.457%
Sarepta Therapeutics, Inc. -267.82 Million USD 94.557%
Inozyme Pharma, Inc. -75.64 Million USD 80.729%
Revolution Medicines, Inc. -487.18 Million USD 97.008%
Nymox Pharmaceutical Corporation -6.65 Million USD -119.149%
Third Harmonic Bio, Inc. -43.95 Million USD 66.834%
ArriVent BioPharma, Inc. Common Stock -74.59 Million USD 80.456%
AN2 Therapeutics, Inc. -69.63 Million USD 79.065%
Anixa Biosciences, Inc. -11.01 Million USD -32.393%
Vertex Pharmaceuticals Incorporated 4.3 Billion USD 100.338%
Denali Therapeutics Inc. -196.69 Million USD 92.589%
Revelation Biosciences, Inc. -8.65 Million USD -68.399%
Veru Inc. -93.78 Million USD 84.456%
Corvus Pharmaceuticals, Inc. -23.32 Million USD 37.512%
Cingulate Inc. -22.75 Million USD 35.948%
Passage Bio, Inc. -108.38 Million USD 86.551%
Context Therapeutics Inc. -25.07 Million USD 41.858%
Exicure, Inc. -14.99 Million USD 2.789%
Day One Biopharmaceuticals, Inc. -206.06 Million USD 92.926%
Oramed Pharmaceuticals Inc. -40.59 Million USD 64.092%
Scinai Immunotherapeutics Ltd. -9.71 Million USD -50.024%
Rhythm Pharmaceuticals, Inc. -184.35 Million USD 92.093%
Nuvalent, Inc. -149.49 Million USD 90.248%
ABVC BioPharma, Inc. -8.21 Million USD -77.42%
Carisma Therapeutics, Inc. -88.73 Million USD 83.571%
Unicycive Therapeutics, Inc. -20.77 Million USD 29.827%
OmniAb, Inc. -69.41 Million USD 79.0%
Anew Medical, Inc. -1.3 Million USD -1020.643%
Fennec Pharmaceuticals Inc. -12.77 Million USD -14.147%
Lipocine Inc. -17.93 Million USD 18.701%
Lexeo Therapeutics, Inc. Common Stock -68.51 Million USD 78.723%
Nautilus Biotechnology, Inc. -76.15 Million USD 80.857%
SAB Biotherapeutics, Inc. -38.07 Million USD 61.713%
G1 Therapeutics, Inc. -39.52 Million USD 63.119%
Bellerophon Therapeutics, Inc. -22.38 Million USD 34.874%
Sage Therapeutics, Inc. -579.84 Million USD 97.486%
Ocugen, Inc. -65.53 Million USD 77.754%
Mind Medicine (MindMed) Inc. -93.86 Million USD 84.47%
Q32 Bio Inc. -92.1 Million USD 84.172%
Brainstorm Cell Therapeutics Inc. -21.43 Million USD 32.004%
Alumis Inc. Common Stock -158.17 Million USD 90.784%
Equillium, Inc. -14.52 Million USD -0.384%
Kyverna Therapeutics, Inc. -62.4 Million USD 76.64%
Coya Therapeutics, Inc. -7.9 Million USD -84.451%
CNS Pharmaceuticals, Inc. -18.86 Million USD 22.726%
Galera Therapeutics, Inc. -46.95 Million USD 68.951%
Evelo Biosciences, Inc. -108.46 Million USD 86.56%
Comera Life Sciences Holdings, Inc. -11.97 Million USD -21.786%
Dominari Holdings Inc. -21.79 Million USD 33.117%
Edesa Biotech, Inc. -9.22 Million USD -58.063%
vTv Therapeutics Inc. -25.5 Million USD 42.837%
Bio-Techne Corporation 206.68 Million USD 107.053%
Agios Pharmaceuticals, Inc. -391.48 Million USD 96.276%
Harmony Biosciences Holdings, Inc. 192.03 Million USD 107.591%
Prelude Therapeutics Incorporated -132.27 Million USD 88.979%
Candel Therapeutics, Inc. -38.39 Million USD 62.028%
iTeos Therapeutics, Inc. -151.1 Million USD 90.352%
Nkarta, Inc. -131.65 Million USD 88.927%
BioCardia, Inc. -11.64 Million USD -25.196%
Iterum Therapeutics plc -47.46 Million USD 69.289%